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Abstract Esophageal atresia and tracheoesophageal fistula
(EA/TEF)aremajorcongenitalmalformationsaffecting1:3500
live births. Current research efforts are focused on understand-
ing the etiology of these defects. We describe well-known
animal models, human syndromes, and associations involving
EA/TEF, indicating its etiologically heterogeneous nature.
Recent advances in genotyping technology and in knowledge
of human genetic variation will improve clinical counseling on
etiologic factors. This review provides a clinical summary of
environmental and genetic factors involved in EA/TEF.
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Introduction
Esophageal atresia (EA) and tracheoesophageal fistula (TEF)
are congenital malformations that occur approximately in
1:3500 live-born infants [1]. Five subtypes are described,
based on the location of the atresia and the type of
connection between trachea and esophagus [2]. Associated
anomalies occur in 50% of patients and include vertebral,
anal, cardiovascular, tracheoesophageal, renal, and limb
abnormalities (occurring together in the VACTERL
association). Better surgical techniques and pre- and
postoperative care have improved the prognosis of EA/
TEF over the past decades, but patients still have
significant short- and long-term morbidity [3￿]. As with other
congenital malformations, EA/TEF occurs at an increased
rate in twins, but usually affects only one twin [1]. Once a
couple has one child with EA/TEF, the risk of having a
second child with this anomaly is increased to 1% [4].
The pathologic mechanism leading to EA/TEF is
unknown. The trachea, esophagus, and lungs are foregut-
derived structures. During the fourth week of embryonic
life, the foregut divides into a ventral respiratory part and a
dorsal esophageal part. The underlying mechanism of
separation is not known.
EA/TEF is thought to be a multifactorial complex
disease, with involvement of genetic and environmental
factors. In 6% to 10% of patients a defined genetic
syndrome can be diagnosed, leaving 90% of patients of
unknown etiology [5]. This paper aims to give an overview
of current knowledge and gaps in knowledge on the
etiology of EA/TEF. In this review we distinguish between
complex genetic syndromes and associations to facilitate
targeted genetic follow-up and counseling.
Environmental Factors
Various environmental factors have been suggested as risk
factors for the development of tracheoesophageal anomalies,
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sex hormones [7], maternal alcohol and smoking [8],
infectious diseases [9], and working in agriculture or
horticulture [10]. Previous studies from our group impli-
cate a possible role for maternal in utero exposure to
diethylstilbestrol (DES) [11]. Observations in insulin-
dependent diabetic mothers suggest that first trimester
exposure to maternal diabetes is associated with the
development of congenital anomalies, including EA/TEF
and VACTERL-associated anomalies [12]. Very recently,
studies from the European Surveillance of Congenital
Anomalies (EUROCAT) birth registry network found that
older mothers are at significantly greater risk of having a
child with EA [13￿].
Administration of the anthracycline antibiotic adria-
mycin to pregnant rats causes EA/TEF and other major
congenital anomalies in the offspring [14]. However, no
such association has been reported for humans [15]. A role
for vitamin A deficiency in the development of EA/TEF
has also been suggested. A vitamin A–deficient diet given
to pregnant rats caused severe congenital anomalies in the
offspring, including agenesis of the lung and TEF [16].
Ethylnitrosourea (ENU), an alkylating and mutagenic
agent, induced a recessive mouse mutation with a
phenotype that includes abnormal tracheoesophageal
septation and VACTERL-associated anomalies [17]. So
far, no specific environmental risk factor has consistently
been identified.
Genetic Factors
Human Syndromes and Associations Involving EA/TEF
More than 50% of EA/TEF patients have associated
anomalies. Certain anomalies, such as cardiovascular
defects, renal agenesis, microcephaly, duodenal atresia,
limb reduction defects, and polycystic kidney are especially
prevalent in patients with EA/TEF [18, 19]. EA/TEF may
be present in several syndromes and associations, as
described in Table 1.
The department of Pediatric Surgery at the Erasmus
MC—Sophia Children’s Hospital admitted more than
300 EA/TEF patients from 1988 to 2009. In 29 patients,
a chromosomal abnormality or a single gene disorder
was causative to the EA/TEF phenotype. One in every
10 patients had a defined syndrome, which is in line with
the literature. Many of the known genetic syndromes
were seen in this cohort, including all full trisomies
(Down syndrome, Edwards syndrome, Patau syndrome),
single gene disorders (eg, CHARGE syndrome, Feingold
syndrome, Opitz syndrome, and Fanconi anemia), and
some less frequent syndromes (eg, Holt-Oram syndrome
and Townes Brocks syndrome). The distribution of
syndromes is according to the literature [5, 20].
More than 30% of EA/TEF cases in our cohort
(syndromal cases excluded) were defined as VACTERL-
associated. EA/TEF is a component of the VACTERL
association, which includes vertebral, anal, cardiovascular,
tracheoesophageal, renal, and limb anomalies, and is seen
in 10% to 30% of EA/TEF patients [1, 19]. The use of this
acronym as a clinical entity is still being debated, as is the
minimum number of defects that must be present.
Of the VACTERL components, the vertebrae/ribs and
the cardiovascular system are most commonly affected in
combination with EA/TEF [23]. EA/TEF occasionally
occurs in combinations with hemifacial microsomia, cardiac,
vertebral, and/or central nervous system anomalies
(Goldenhar syndrome), but no genetic basis has been
described for this syndrome [21].
VACTERL associated patients are of interest in the
search for new genetic factors underlying foregut-related
and associated anomalies. However, the combinations of
EA/TEF and its associated anomalies resemble and/or
overlap phenotypically with defined syndromes, such as
CHARGE syndrome, Feingold syndrome, and 22q11
deletion syndrome (discussed below). It is not easy,
therefore, to discriminate between the causal syndromes,
the more so as the etiology of VACTERL association is still
unclear. Specific phenotypes, such as VACTERL-associated
anomalies combined with hydrocephalus, did reveal
causative mutations in the genes FANCB and PTEN [22,
23]. A recent study found deletions in the FOX gene
cluster on chromosome 16q24, and mutations in the
FOXF1 gene, in patients with alveolar capillary dysplasia
combined with VACTERL-associated anomalies, includ-
ing EA/TEF [24￿￿].
Single Gene Disorders Involving EA/TEF
Feingold Syndrome
Feingold syndrome is caused by germline mutations in,
or deletions of, the MYCN gene on chromosome 2p24.1.
It is the most frequent cause of familial syndromic
gastrointestinal atresias. About 30% to 40% of patients
diagnosed with Feingold syndrome have EA/TEF [25].
Marcelis et al. [26￿￿] reviewed the clinical features of
Feingold syndrome in relation to the genotype; 23
different mutations of the MYCN gene and five deletions
encompassing MYCN have been described over the years.
The authors suggest that the presence of digital anomalies
in combination with microcephaly is enough to justify
MYCN analysis [26￿￿]. Such analysis should also be
considered in patients with EA/TEF in combination with
microcephaly.
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About 10% of patients with CHARGE syndrome display EA/
TEF. This well-defined syndrome—involving coloboma,
heart anomalies, choanal atresia, growth and/or mental
retardation, genital and ear anomalies—is caused by muta-
tions in the chromodomain helicase DNA-binding (CHD7)
gene, present in about 60% of CHARGE patients [27]. This
gene is thought to have a role in early embryonic
development affecting epigenetic regulation by chromatin
Table 1 Genetic syndromes and associations involving esophageal atresia and tracheoesophageal fistula
OMIM Gene
(s)
Locus Major defects
a
Single gene disorders
Feingold syndrome 164280 MYCN 2p24.1 Intestinal atresias, microcephaly, learning disability, CHD, limb defects,
short stature
CHARGE syndrome 214800 CHD7 8q12 Coloboma, CHD, choanal atresia, GR, genitourinary and ear anomalies/
deafness
AEG syndrome 206900 SOX2 3q26.3-q27 Clinical anophthalmia, GD, mesial temporal abnormalities of the brain
Pallister-Hall syndrome 146510 GLI3 7p13 Laryngotracheoesophageal cleft, hypothalamic hamartoblastoma,
pituitary dysfunction, AA, limb defects
Opitz G syndrome 300000 MID1 Xp22 Laryngotracheoesophageal cleft, hypertelorism, hypospadias, cleft lip/
palate, CHD, AA, developmental delay
Fanconi anemia 607139 FANCA 16q24.3 Anemia, abnormal skin pigmentation, short stature, microphthalmia,
microcephaly, susceptibility to cancer, CHD, limb and renal defects
VACTERL+hydrocephalus 227645 FANCC 9q22.3 VACTERL-associated defects, hydrocephalus, Arnold-Chiari malfor-
mation, cleft palate, incomplete lung lobation 605724 FANCD1 13q12.3
227646 FANCD2 3p25.3
602956 FANCG 9p13
300514 FANCB Xp22.31
VACTERL+hydrocephalus 276950 PTEN 10q23.31 VACTERL-associated defects, macrocephaly, ventriculomegaly
Chromosomal abnormalities
Full trisomies – Chromosomes
13,18,21
Major congenital anomalies, including MR, CHD, gastrointestinal
atresias, Hirschsprung disease, dysmorphic features
22q11 deletion (DiGeorge)
syndrome
188400 TBX1
b 22q11.2 CHD, cleft palate, facial dysmorphism, hypocalcaemia, hypertelorism,
hypospadias, thymic hypoplasia, and midline defects
Opitz syndrome 145410 TBX1
b 22q11.2 Hypertelorism, laryngotracheoesophageal cleft, cleft lip/palate, GD,
MR, CHD
13q deletion – ZIC2
b 13q22-qter Central nervous system malformations, intestinal atresias, GR,
coloboma, genitourinary, midline and VACTERL-associated defects
17q deletion – RARα
b 17q21.3-
q24.2
MR, conductive hearing loss, impaired vision, craniofacial and skeletal
defects NOG
b
TBX4
b
16q24 deletion – FOXF1
b 16q24.1 ACD, VACTERL-associated defects, urinary tract obstruction
Associations
VACTERL association 192350 –– Vertebral, anal, cardiovascular, renal and limb defects
VACTERL+hydrocephalus 314390 – X-linked VACTERL-associated defects, hydrocephalus
Oculo-Auriculo-Vertebral
Spectrum (OAVS)/Goldenhar
syndrome
164210 –– Hemifacial microsomia, CHD, vertebral and central nervous system
anomalies
Martinez-Frias syndrome 601346 –– Neonatal diabetes mellitus, intestinal atresias, hypoplastic pancreas and
gallbladder, biliary atresia, hypospadias
aOther defects in combination with esophageal atresia and tracheoesophageal fistula
bGene(s) of interest on chromosomal locus
AA anal atresia/imperforate anus; ACD alveolar capillary dysplasia; AEG anophthalmia-esophageal-genital; CHARGE syndrome coloboma, heart
anomalies, choanal atresia, growth and/or mental retardation, genital and ear anomalies; CHD congenital heart defects; GD genital defects,
including cryptorchidism, hypospadias, genital hypoplasia; GR growth retardation; MR mental retardation; VACTERL vertebral, anal,
cardiovascular, tracheoesophageal, renal, and limb abnormalities
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regulatory function and involvement in CHARGE syndrome
and foregut development should be clarified in functional
studies in humans and animal models.
AEG Syndrome
Deletions and mutations of the SOX2 gene are causative for
the phenotype of clinical anophthalmia/optic nerve hypo-
plasia, esophageal atresia, and/or genital anomalies in the
AEG syndrome [28]. Studies in chickens and Xenopus
implicate a role for Sox2 in the developing foregut. Que et
al. [29￿￿,30] demonstrated EA/TEF in Sox2 mutant mice
and thus provided evidence that down regulation of Sox2
plays a role in the etiology of EA. The proven relation
between murine models and the human phenotype was a
breakthrough in the knowledge about syndromic EA/TEF.
Pallister-Hall Syndrome
Pallister-Hall syndrome includes bifid epiglottis, hypo-
thalamic hamartoblastoma, postaxial polydactyly, anal
atresia, and occasionally laryngeal clefts. Mutations in
the GLI3 gene can cause Pallister-Hall syndrome [31].
The foregut-related anomalies, such as laryngeal clefts and
lobulation defects of the lungs, form a phenotypic link
between human Pallister-Hall patients and the combined
knockout mice for Gli2/Gli3. This provides evidence that
the Gli-genes and their pathways are important in foregut
development [32].
Opitz G Syndrome
Opitz G syndrome is characterized by midline abnormalities
with mental retardation and agenesis of the corpus callosum.
Even though EA/TEF is rare in Opitz G syndrome, the
combination of EA/TEF with corpus callosum agenesis
warrants testing for mutations in the MID1 gene, causing
the X-linked form of Opitz syndrome. Laryngotracheoeso-
phageal defects in general are present in most MID1-mutated
males, but EA/TEF is rare [33]. In addition, deletions on
chromosome 22q11.2 cause the autosomal-dominant form of
Opitz syndrome, which has the same size of the deletion as
observed in DiGeorge syndrome [34]. Also, several cases of
EA/TEF have been described in patients with DiGeorge
syndrome (see below).
Fanconi Anemia
Fanconi anemia (FA) is a genetically and phenotypically
heterogeneous syndrome characterized by progressive bone
marrow failure and early occurrence of acute myeloid
leukemia, combined with several congenital malformations,
including gastrointestinal malformations. Thirteen genetic
subtypes have been described (A, B, C, D1, D2, E, F, G, I,
J, L, M, and N), of which FANCA, FANCC, and FANCG are
the three most common disease-causing genes [35].
Mutations in the FANCA, FANCB, FANCC, FANCD1
(BRCA2), FANCD2,a n dFANCG genes have been described
in patients with EA/TEF with various combinations of
defects, including microcephaly, short stature, pigment
changes, and several VACTERL-associated anomalies,
including heart, renal, and limb defects [22, 35–39]. EA/
TEF is not a common feature of FA, but gastrointestinal
malformations, including duodenal atresia, anorectal
malformations, and EA/TEF, are seen in 14% of all FA
patients [35]. In addition, mutations in the FANCB gene,
on chromosome Xp22.31, were causes of X-linked
VACTERL with hydrocephalus in patients who also had
EA/TEF, lung lobulation defects, and confirmed central
nervous system anomalies [22]. The diagnosis of Fanconi
anemia calls for early therapeutic interventions and
chromosome breakage studies. Faivre et al. [36]a d v i s e d
performance of breakage studies in patients with common
VACTERL-associated anomalies, including EA/TEF, in
c o m b i n a t i o nw i t hs k i np i g m e n t ation abnormalities, growth
retardation, microcephaly, and/or dysmorphism.
Chromosomal Abnormalities
Many well-known chromosomal aberrations are observed
in EA/TEF patients, such as Down syndrome (trisomy 21),
Edwards syndrome (trisomy 18), and Patau syndrome
(trisomy 13) [1]. Deletions on several chromosomal loci,
including 22q11 (DiGeorge syndrome), distal 13q,
17q21.3-q24.2, and 16q24.1 are found in some cases
[24￿￿, 40–43]. The paper by Felix et al. [42] reviewed the
structural chromosomal anomalies reported in 30 patients.
Some of the above-mentioned deletions are of interest,
because the deleted loci include several candidate genes for
EA/TEF, for example, the 17q21.3-q24.2 region including
NOG and TBX4. Recently Stankiewicz et al. [24￿￿]
described deletions on the16q24.1 locus, including the
forkhead genes FOXF1, FOXC2,a n dFOXL1. Of these
transcription factors, FOXF1 is of particular interest,
because heterozygote knockout mice for this protein have
EA/TEF.
Bettermolecularcytogenetic techniquesallowscreeningof
large cohorts of patients with congenital anomalies; the copy
number variations in microarray studies yield additional
deletions and duplications. Such studies in EA/TEF patients
are expected to reveal new candidate regions. We confirmed
several chromosomal aberrations in patients with EA/TEF:
Triple-X syndrome, Xp duplications, 22q11 microduplication
syndrome, and a 5q11.2 deletion (unpublished data).
Microarray studies will also provide more insight into
218 Curr Gastroenterol Rep (2010) 12:215–222the polymorphic regions of the human genome in
relation to inherited aberrations in patients with congenital
anomalies.
Murine Models
Several murine models are described to cause tracheoesopha-
gealanomalies(Table 2)[ 17, 30, 44]. Genes of developmental
pathways are involved, including vitamin A effectors (Rarα,
Rarβ), effectors of the sonic hedgehog (SHH) pathway (Shh,
Gli2, Gli3, Foxf1), other homeobox-containing transcription
factors and their regulators (Hoxc4, Ttf-1, Pcsk5), and
developmental transcriptional regulators (Tbx4, Sox2).
Research into the human homologues of these genes has
shed some light on the molecular basis underlying some
human cases of EA/TEF. For example, Que et al. [30]f o u n d
that 70% of null mutant mice for Noggin display EA/TEF. In
several human TEF cases there is a deletion of the 17q21.3-
24.2 locus, which includes the human orthologue NOG [30,
43]. Mice haploinsufficient for Foxf1 may show EA/TEF and
other foregut-derived anomalies, including lung hypoplasia
and lobulation defects [45]. A patient with a heterozygote
deletion on chromosome 16q24, including the FOXF1 gene,
displayed lung anomalies, EA/TEF and other VACTERL-
associated features [24￿￿]. The Gli2 and Gli3 genes are
essential for formation of the trachea and the esophagus.
Deletions of these genes are associated with congenital
defects that resemble the VACTERL association, at least in
mice [30, 32]. Szumska et al. [17] describe an ENU-induced
recessive mouse mutation in the Pcsk5 gene, a regulator of
Hox genes. Such mutations,in a heterozygote form, were also
present in two patients with EA/TEF and features of
VACTERL association. However, in these cases the mutations
were inherited from a phenotypically normal parent. The
etiologic role of these mutations remained unclear [17].
In conclusion, EA/TEF can be part of a spectrum of
anomalies in specific syndromes with a known cause or it
can be part of an association (Fig. 1). Clinicians should be
aware of specific combinations of anomalies, and should
these occur, consider counseling by a clinical geneticist.
Strategies and Future Prospects
Phenotypic Approach
Patients presenting with esophageal atresia receive treatment
by standardized clinical and surgical protocols. Adding
standardized genetic protocols for counseling and research
would provide a good opportunity to unravel the genetic
background of EA and other congenital abnormalities. The
clinical protocol for all patients with EA/TEF should include
an echocardiogram and vertebral and limb radiographs,
complemented with renal ultrasound evaluation if other
features of the VACTERL association are present.
Genotypic Approach
Counseling by a clinical geneticist is advised, including
standard karyotyping and screening for subtelomeric
Table 2 Overview of genes essential for tracheoesophageal development and their human homologues
Gene Mutant phenotype Human
homologue
Human locus
Shh
−/− EA; TEF; lungs form rudimentary sacs SHH 7q36
Rarα
−/−;β2
−/−or
Rarα1
−/−;β
−/−
TEF; lung hypoplasia or agenesis RARα; RARβ RARα: 17q21.1; RARβ: 3p24
Gli2
−/−; Gli3
+/− EA; TEF; severe lung phenotype GLI2; GLI3 GLI2: 2q14; GLI3: 7p13
Gli2
−/−; Gli3
−/− No formation of esophagus, trachea, and lungs
Foxf1
−/− Lethal before embryonic day 10; extra-embryonic defects FOXF1 16q24.1
Foxf1
+/− EA; TEF; lung immaturity/hypoplasia; lobulation defects FOXF1 16q24.1
Ttf-1
−/− TEF; rudimentary peripheral lung primordial TTF1 14q13
Sox2
-/− EA; TEF; lung branching defects SOX2 3q26.3-q27
Noggin
−/− EA; TEF; lung branching defects; abnormal notochord morphogenesis NOG 17q22
Pcsk5 C470R
mutant
a
Abnormal tracheoesophageal septation; hypoplastic lungs PCSK5 9q21.3
Hoxc4
−/− Partially or completely blocked esophageal lumen; disruption
of esophageal musculature
HOXC4 12q13.3
Tbx4 misexpression TEF TBX4 17q21-q22
aEthylnitrosourea (ENU)-induced mouse mutation
EA esophageal atresia; TEF tracheoesophageal fistula
(Adapted from Felix et al. [44], supplemented with findings from recent studies by Szumska et al. [17] and Que et al. [29￿￿, 30])
Curr Gastroenterol Rep (2010) 12:215–222 219aberrations with multiplex ligation-dependent probe amplifi-
cation. Clinical data should be reviewed and stored in
comprehensive databases, together with genetic information,
including pedigrees, DNA, tissue, and cell lines. With
improvements in microarray technologies, genome-wide
screening for copy number variations might replace standard
karyotyping in the near future.
Epidemiologic Approach
Strategies that provide more insight into new etiologic factors
should be in place to find more evidence for gene-
environment interactions, to explore possible molecular
mechanisms, and to find new genetic pathways. Environmen-
talfactorsinfamiliesofpatientswithEA/TEFcouldbefurther
explored by means of structured and validated questionnaires,
adding to the knowledge gained from case-control studies
[10]. Such studies require large cohorts, as have been used in
population-based registries for surveillance of congenital
anomalies, such as EUROCAT, the International Clearing-
house for Birth Defects Surveillance and Research, and the
California Birth Defects Monitoring Program.
Experimental Approach
Studies in animal models implicate an essential role for sonic
hedgehogsignalinganditsdownstreameffectorsinthecorrect
embryogenesis of the foregut. Better understanding of normal
and abnormal development of the foregut could be achieved
by focusing on the overlapping effectors of Shh-signaling,
described in patients and animal models, for example, Gli2,
Gli3, FOXF1, MID1, Noggin, Bmp4, and TBX1 [30, 46￿].
Advances in genotyping technology and in knowledge
of human genetic variation have enabled genome-wide
association studies to identify susceptibility for common
diseases, but also for congenital abnormalities, as proven in
neural tube defects [47]. This approach requires large
cohorts so as to provide statistical and clinical significance.
Direct sequencing of candidate genes in patients and
controls will provide an alternative approach that could
reveal low-frequency alleles that influence disease suscep-
tibility [48]. In addition, next generation sequencing will
soon be an excellent tool in the search for new pathogenic
mutations and copy number variations [49]. Also, there is
increasing evidence that epigenetic modifications play an
important role in developmental defects through DNA
methylation and histone modifications [50]. A unifying
approach seems to be the answer, therefore: analysis of
multiple candidate genes should be done in large groups of
well-genotyped individuals using next generation high-
throughput genomic technology. This will be of great help
in detecting possible gene-gene interactions as well as a
possible role for copy number variations and regulatory
mutations in patients with EA/TEF.
Conclusions
Many genetic pathways have been implicated in the
development of EA/TEF. Patients with distinct phenotypes
Fig. 1 Schematic representation of the commonest type of EA/TEF and
genetic syndromes and genes involved. The text boxes list the genetic
syndromes and genes most frequently found to be involved in EA/TEF.
EA —esophageal atresia; TEF —tracheoesophageal fistula; *—lung
phenotype present; **—deletion in a single case; L—lung; E—
esophagus; T—trachea; S—stomach; del—deletion; mut—mutation.
AEG syndrome—Anophthalmia/optic nerve hypoplasia, Esophageal
atresia, and/or Genital anomalies; CHARGE syndrome—Coloboma,
Heart anomalies, choanal Atresia, growth and/or mental Retardation,
Genital and Ear anomalies; VACTERL-H association—vertebral, anal,
cardiovascular, tracheal, esophageal, renal, and limb abnormalities
occurring together, with hydrocephaly
220 Curr Gastroenterol Rep (2010) 12:215–222may be diagnosed with genetic syndromes such as Feingold
syndrome, AEG syndrome, and CHARGE syndrome.
There is a substantial gap in our knowledge of how
environmental factors combined with genetic factors would
disrupt foregut development. We would do well to “mind
the gap” by performing clinical studies focusing on
phenotyping, combined with targeted molecular genetic
studies. In the near future, studies in large cohorts will lead
to the discovery of new genes, genetic pathways, and
perhaps environmental factors.
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